Learn about a local study testing a potential new treatment

Indago Research in Hialeah is conducting a clinical study to evaluate a potential new treatment for Chronic Obstructive Pulmonary Disease (COPD) for those experiencing flare-ups.

Participants are needed to help learn more about a potential new treatment option.

Do You Qualify?

We’re seeking the following people to participate in this study:

  • Aged 40 years or older
  • Have COPD with occasional flare-ups requiring treatment
  • Currently prescribed daily inhaled maintenance therapy, with a stable dose for at least 3 months for COPD
  • Be a current or former smoker who quit 6 or more months before entering the study
  • Have had at least one COPD exacerbation in the past 12 months

There’s no cost to participate in this study, no placebo, and you do not need health insurance. Reimbursement for reasonable expenses such as travel may also be available for qualified participants.

Learn More

To find out if you or a loved one are eligible for this study, please contact us at 786-772-0510.

Getting to the heart of cardiovascular disease

The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).

If you are interested in taking part in the VICTORION-2 PREVENT Study, we’re searching for people who:

· Are 40 years of age and older

· Have previously experienced a heart attack, stroke or reduced blood flow to limbs caused by narrowed arteries (peripheral arterial disease)

· Are currently receiving a high-intensity statin (medication that lowers the level of harmful cholesterol in the blood)

There are other criteria that you will need to meet to qualify for participation in this study, which the study team can discuss with you.

For further information about the VICTORION-2 PREVENT Study, visit www.V2PSTUDY.com or contact:

786-772-0510

The Beacon Study is seeking volunteers to test an enlightening at-home investigational device. We’re looking at how safe the investigational device is and how well it may work to speed recovery in people with COVID-19.

The SURMOUNT-MMO Study is evaluating the effectiveness of an investigational medication (trial treatment) on reducing health risks that are commonly found in people who are living with obesity or are overweight. This clinical trial is focusing particularly on cardiovascular (heart) disease and other heart health risks.

  • Indago’s Virtual Assistant Beta

    • Virtual Assistant: Greetings, I am Indago's Virtual Assistant. Kindly note that the information I provide may not be guaranteed for accuracy. How may I help you? También hablo español y otros idiomas

    AI is thinking ...
  • Virtual Assistant
    Close
    Skip to content NULL